Document Detail


Treatment of lupus nephritis.
MedLine Citation:
PMID:  20979555     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Renal involvement in systemic lupus erythematosus patients is a severe disease manifestation characterized by various clinical and histopathological alterations. The revised International Society of Nephrology/Renal Pathology Society 2003 classification defines the subclasses of lupus nephritis (LN) according to their pathological glomerular patterns, which has a crucial impact on the prognosis and treatment options for LN patients. There are widely accepted therapeutic agents available, such as cyclophosphamide, mycophenolate mofetil, azathioprine and corticosteroids. Several trials have tried to determine a gold standard for induction and maintenance therapy in LN, and the place of newer drugs, biologicals, has been investigated. We review recently reported data on current treatment regimens in LN, in particular in the context of the International Society of Nephrology/Renal Pathology Society 2003 classification.
Authors:
Sebastian Dolff; Jo Hm Berden; Marc Bijl
Related Documents :
9378015 - The japan society of coloproctology: a brief history.
19900925 - Intergenerational wealth transmission and the dynamics of inequality in small-scale soc...
6960885 - The epidemiology of psychiatric illness in industrialised society.
10359945 - Special communicationthe critical role of mechanical forces in blood vessel development...
22050135 - Ibs: transforming our governance.
17781795 - Correction.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Expert review of clinical immunology     Volume:  6     ISSN:  1744-8409     ISO Abbreviation:  Expert Rev Clin Immunol     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101271248     Medline TA:  Expert Rev Clin Immunol     Country:  England    
Other Details:
Languages:  eng     Pagination:  901-11     Citation Subset:  IM    
Affiliation:
Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands. sebastian.dolff@uk-essen.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  ABO blood group incompatibility: a diminishing barrier to successful kidney transplantation?
Next Document:  Current understanding and management of giant cell arteritis and polymyalgia rheumatica.